| Name | statins |
|---|---|
| Synonyms | STN; statin; statins |
| Name | phosphorus |
|---|---|
| CAS | phosphorus |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 20008688 | McCullough PA, Chinnaiyan KM: Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med. 2009 Dec 14;169(22):2064-70. In 5 trials in subjects with cardiovascular disease (CVD) (n = 2135; age, ~64 years; ~39% women; follow-up, ~26 months), therapies included statins (n = 1370), placebo (n = 564), and antihypertensives (n = 201). In 5 trials in subjects with chronic kidney disease (n = 477; age, ~55 years; ~34% women; follow-up, ~14 months), interventions included low-phosphorus diet (n = 29), sevelamer hydrochloride (n = 229), and -based binders (n = 219). |
1(0,0,0,1) | Details |
| 19793187 | Lerner RG, Aronow WS, Sekhri A, Palaniswamy C, Ahn C, Singh T, Sandhu R, McClung JA: use and the risk of valvular calcification. J Thromb Haemost. 2009 Dec;7(12):2023-7. Epub 2009 Sep 28. Logistic regression analyses were also conducted to investigate whether the relationship stands after adjustment for confounding risk factors such as age, sex, race, ejection fraction, smoking, hypertension, diabetes, dyslipidemia, coronary artery disease (CAD), glomerular filtration rate, phosphorus, -phosphorus product, alkaline phosphatase, use of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins. |
31(0,1,1,1) | Details |